Literature DB >> 22214705

The influence of on-pump and off-pump coronary artery bypass grafting on hemorheological parameters.

J Papp1, A Toth, B Sandor, R Kiss, M Rabai, P Kenyeres, I Juricskay, G Kesmarky, S Szabados, K Toth.   

Abstract

Conditions during coronary artery bypass grafting (CABG) performed on beating heart (off-pump) are more physiological than using extracorporeal perfusion (on-pump). The present study aims to examine the hemorheological aspects of the two techniques. Blood samples were taken from patients undergoing on-pump (n = 25) and off-pump (n = 22) CABG, upon arrival to the operating theatre, after 20 and 40 minutes during the operation, after closing the thorax, on the 1st and 2nd postoperative days, and during the 2nd and 6th month control check-ups. Hematocrit (Hct), plasma and whole blood viscosity (PV, WBV; Hevimet 40 capillary viscometer), red blood cell (RBC) aggregation (Myrenne RBC aggregometer, LORCA) and deformability (LORCA, Carat FT-1 filtrometer), and platelet aggregation (Carat TX4 aggregometer) were determined. The morphology of red blood cells was investigated by scanning electron microscopy (SEM). Hct, PV, WBV and RBC aggregation decreased significantly during the early phase of the surgery, they started to recover during the postoperative period, and reached the baseline values by the 2nd and 6th month control check-ups. These parameters were significantly lower in samples taken after 20 and 40 minutes in the on-pump group. SEM showed rather damaged and malformed cells in case of on-pump surgery. Ektacytometry showed no significant difference, but RBC deformability was impaired during on-pump surgery when measured by filtrometry. The decrease in platelet aggregation was more pronounced by the end of surgery in case of on-pump technique. During CABG rheological parameters change less when using the off-pump method, and mechanical damage of RBCs are also smaller. The off-pump technique seems to be favorable from a hemorhelogical point of view.

Entities:  

Mesh:

Year:  2011        PMID: 22214705     DOI: 10.3233/CH-2011-1484

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  6 in total

1.  Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients.

Authors:  Osman N Salaria; Viachaslau M Barodka; Charles W Hogue; Dan E Berkowitz; Paul M Ness; Jack O Wasey; Steven M Frank
Journal:  Anesth Analg       Date:  2014-06       Impact factor: 5.108

2.  The role of hemorheological factors in cardiovascular medicine.

Authors:  A Toth; J Papp; M Rabai; P Kenyeres; Zs Marton; G Kesmarky; I Juricskay; H J Meiselman; K Toth
Journal:  Clin Hemorheol Microcirc       Date:  2014       Impact factor: 2.375

3.  Absence of association between whole blood viscosity and delirium after cardiac surgery: a case-controlled study.

Authors:  Shokoufeh CheheiliSobbi; Mark van den Boogaard; Arjen J C Slooter; Henry A van Swieten; Linda Ceelen; Gheorghe Pop; Wilson F Abdo; Peter Pickkers
Journal:  J Cardiothorac Surg       Date:  2016-08-05       Impact factor: 1.637

4.  Impact of surface-area-to-volume ratio, internal viscosity and membrane viscoelasticity on red blood cell deformability measured in isotonic condition.

Authors:  Céline Renoux; Magalie Faivre; Amel Bessaa; Lydie Da Costa; Philippe Joly; Alexandra Gauthier; Philippe Connes
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

5.  Hematological Changes in Patients Undergoing Coronary Artery Bypass Surgery: a Prospective Study.

Authors:  Sotir Lako; Teuta Dedej; Tatjana Nurka; Vera Ostreni; Aurel Demiraj; Roland Xhaxho; Edvin Prifti
Journal:  Med Arch       Date:  2015-06-10

6.  The impact of circulation in a heart-lung machine on function and survival characteristics of red blood cells.

Authors:  Joames Freitas Leal; Harry Vermeer; Dan Lazari; Leen van Garsse; Roland Brock; Merel Adjobo-Hermans; Giel Bosman
Journal:  Artif Organs       Date:  2020-04-03       Impact factor: 3.094

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.